These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35524900)

  • 1. Value of [
    Deleu AL; Laenen A; Decaluwé H; Weynand B; Dooms C; De Wever W; Jentjens S; Goffin K; Vansteenkiste J; Van Laere K; De Leyn P; Nackaerts K; Deroose CM
    EJNMMI Res; 2022 May; 12(1):28. PubMed ID: 35524900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors.
    Komek H; Can C; Urakçi Z; Kepenek F
    Nucl Med Commun; 2019 May; 40(5):517-524. PubMed ID: 30694875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic and prognostic role of combined [
    Albano D; Dondi F; Bauckneht M; Albertelli M; Durmo R; Filice A; Versari A; Morbelli S; Berruti A; Bertagna F
    Eur Radiol; 2023 Jun; 33(6):4167-4177. PubMed ID: 36482218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of 18F-FDG and 68Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis.
    Jiang Y; Hou G; Cheng W
    Medicine (Baltimore); 2019 Mar; 98(10):e14769. PubMed ID: 30855482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective head-to-head comparison of
    Jiang Y; Liu Q; Wang G; Sui H; Wang R; Wang J; Zhu Z
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4218-4227. PubMed ID: 35657429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of
    Zhang J; Liu Q; Singh A; Schuchardt C; Kulkarni HR; Baum RP
    J Nucl Med; 2020 Nov; 61(11):1560-1569. PubMed ID: 32169914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostic implications of molecular imaging phenotype of well-differentiated pulmonary carcinoid based on
    Zidan L; Iravani A; Kong G; Akhurst T; Michael M; Hicks RJ
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):204-216. PubMed ID: 32572559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid.
    Venkitaraman B; Karunanithi S; Kumar A; Khilnani GC; Kumar R
    Eur J Nucl Med Mol Imaging; 2014 May; 41(5):856-64. PubMed ID: 24435773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of [
    Li C; Tian Y; Chen J; Jiang Y; Xue Z; Xing D; Wen B; He Y
    Eur Radiol; 2023 Apr; 33(4):2779-2791. PubMed ID: 36394603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
    Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
    Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT rarely provides additional information other than primary tumor detection in patients with pulmonary carcinoid tumors.
    Tatci E; Ozmen O; Gokcek A; Biner IU; Ozaydin E; Kaya S; Arslan N
    Ann Thorac Med; 2014 Oct; 9(4):227-31. PubMed ID: 25276242
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Kersting D; Sandach P; Sraieb M; Wiesweg M; Metzenmacher M; Darwiche K; Oezkan F; Bölükbas S; Stuschke M; Umutlu L; Nader M; Hamacher R; Fendler WP; Wienker J; Eberhardt WEE; Schuler M; Herrmann K; Hautzel H
    J Nucl Med; 2023 Oct; 64(10):1540-1549. PubMed ID: 37474272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptor imaging with [
    Zhao L; Pang Y; Wang Y; Chen J; Zhuang Y; Zhang J; Zhao L; Sun L; Wu H; Chen X; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1360-1373. PubMed ID: 34665275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate preoperative staging with [
    Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
    Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Diagnostic Efficacy of [
    Zhang S; Wang W; Xu T; Ding H; Li Y; Liu H; Huang Y; Liu L; Du T; Zhao Y; Chen Y; Qiu L
    Front Oncol; 2022; 12():925100. PubMed ID: 35847877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superiority of [
    Shen X; Zhou X; Yao Y; Meng X; Song Y; Yang Z; Li N
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3414-3424. PubMed ID: 37316675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparison of three different molecular imaging methods in localization and grading of insulinoma.
    Chang L; Bi X; Li S; Tong Q; Gu Y; He Z; Li Y; Chen Q; Cui J; Yu H; He Q; Liu M
    Front Endocrinol (Lausanne); 2023; 14():1163176. PubMed ID: 37455905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study.
    Rufini V; Lorusso M; Inzani F; Pasciuto T; Triumbari EKA; Grillo LR; Locco F; Margaritora S; Pescarmona E; Rindi G
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4182-4193. PubMed ID: 35674739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.